Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma

Pediatr Blood Cancer. 2020 Nov;67(11):e28460. doi: 10.1002/pbc.28460. Epub 2020 Aug 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Aminopterin / administration & dosage
  • Aminopterin / analogs & derivatives
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology*
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / pathology*
  • Prednisone / administration & dosage
  • Prognosis
  • Splenic Neoplasms / drug therapy
  • Splenic Neoplasms / pathology*

Substances

  • 10-propargyl-10-deazaaminopterin
  • Doxorubicin
  • Cyclophosphamide
  • Aminopterin
  • Prednisone